Wird geladen...
Immunotherapy of melanoma
The immunotherapy is currently changing the landscape of oncology. Nowadays the standard of care in metastatic or unresectable melanoma patients include immunomodulating modalities such as anti-PD-1 drugs (nivolumab, pembrolizumab) and anti-CTLA-4 antibody ipilimumab. The improvements of progression...
Gespeichert in:
| Veröffentlicht in: | Contemp Oncol (Pozn) |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Termedia Publishing House
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5885078/ https://ncbi.nlm.nih.gov/pubmed/29628796 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2018.73889 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|